Search - tctmd.com

Displaying 1 - 20 of 43

Sort: Relevancy | Date

News Opinion Off Script TCT 2019

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

Kwan S. Lee

October 14, 2019

News Conference News TCT 2019

PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries

L.A. McKeown

October 04, 2019

News Conference News TCT 2019

GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients?

Todd Neale

September 30, 2019

News Conference News TCT 2019

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Shelley Wood

September 29, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Four: Costs and Quality of Life Take Center Stage

Shelley Wood

September 29, 2019

News Opinion Off Script TCT 2019

Off Script: The New Gatekeepers of Procedural Education

Kwan S. Lee

September 28, 2019

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Shelley Wood

September 28, 2019

Presentation TCT 2019

TAVR for Aortic Regurgitation: Clinical Device Evaluation Considerations

Presenter: Vinod Thourani

September 27, 2019

Presentation TCT 2019

TAVR for Bicuspid Aortic Stenosis: What Is Known and What Is Not

Presenter: Michael Mack

September 27, 2019

Presentation TCT 2019

Regulatory Considerations for New Valves and Adjunctive Devices

Presenter: Jennifer Bastijanic

September 27, 2019

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Devices: Reimbursement Considerations

Presenter: Lori Ashby

September 27, 2019

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Pivotal Trials: Regulatory Considerations

Presenter: Changfu Wu

September 27, 2019

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Pivotal Trials: Industry Perspectives

Presenter: Ted Feldman

September 27, 2019

Presentation TCT 2019

Pivotal Transcatheter FMR Device Trials: Future Perspectives One Year After COAPT and MITRA-FR

Presenter: Gregg Stone

September 27, 2019

Presentation TCT 2019

Regulatory Considerations for High Bleeding Risk Patients Undergoing PCI

Presenter: Adrian Magee

September 27, 2019

Presentation TCT 2019

Defining High Bleeding Risk: HBR ARC

Presenter: Philip Urban

September 27, 2019

Presentation TCT 2019

Reimbursement Pathways for Shock Devices

Presenter: Lori Ashby

September 27, 2019

Presentation TCT 2019

Designing Controlled Trials for Shock Devices: Population Targets and Safety and Effectiveness Considerations

Presenter: Anthony Gershlick

September 27, 2019

Presentation TCT 2019

Industry Perspectives on Controlled Trials for Shock Devices

Presenter: Seth Bilazarian

September 27, 2019

Advertisement

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries

GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients?

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

TCT 2019 Day Four: Costs and Quality of Life Take Center Stage

Off Script: The New Gatekeepers of Procedural Education

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

TAVR for Aortic Regurgitation: Clinical Device Evaluation Considerations

TAVR for Bicuspid Aortic Stenosis: What Is Known and What Is Not

Regulatory Considerations for New Valves and Adjunctive Devices

Transcatheter Mitral Valve Repair and Replacement Devices: Reimbursement Considerations

Transcatheter Mitral Valve Repair and Replacement Pivotal Trials: Regulatory Considerations

Transcatheter Mitral Valve Repair and Replacement Pivotal Trials: Industry Perspectives

Pivotal Transcatheter FMR Device Trials: Future Perspectives One Year After COAPT and MITRA-FR

Regulatory Considerations for High Bleeding Risk Patients Undergoing PCI

Defining High Bleeding Risk: HBR ARC

Reimbursement Pathways for Shock Devices

Designing Controlled Trials for Shock Devices: Population Targets and Safety and Effectiveness Considerations

Industry Perspectives on Controlled Trials for Shock Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content